Industries > Pharma > Blood Culture Tests Market Report 2019-2029

Blood Culture Tests Market Report 2019-2029

Analysis by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) and End User (Hospital Laboratories, Reference Laboratories), Plus Company and Country Analysis and Forecasts

PUBLISHED: 05 June 2019
PAGES: 201
PRODUCT CODE: PHA0427
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0427 Categories: , Tag:

Market Definition:
• Blood culture tests play a vital role in diagnosis of bacterial, fungal, and mycobacterial among other infections. Various techniques, including conventional/manual and automated blood culture methods, are used by healthcare professionals for the detection of infection.
• To determine the best treatment, blood culture tests can help identify the type of microorganism that is causing an infection.
• Using sterile technique, a sample of blood is placed in a culture media and incubated in a controlled environment for 1 to 7 days. If microorganisms grow they can be identified and tested.

Market Overview and Trends
• The high growth of blood culture tests market is attributed to the quick turnaround time, reduced risk of contamination, and low manual intervention required in automated blood culture
• The technological advancement has led to instruments and software innovation and this will create new opportunities for manufacturers of the blood culture tests market in the coming years.

Market Dynamics:

Factors Influencing the Market Growth:
• Rising prevalence of infectious diseases such as BSIs and sepsis is expected to be main driving factor for the growth of blood culture tests market.
• The increasing number of regulatory approvals and new product launches has enhanced the market growth.
• High demand for advanced products by hospitals and clinical diagnostics laboratories for the detection of bacterial, fungal, and mycobacterial infections is expected to be the driving factor of blood culture tests market.

Factors Restraining the Market Growth:
• The diagnostic products, such as instruments, kits, reagents, media, and assays, undergo rigorous clinical trials prior to a regulatory approval. Stringent government regulations for the development and manufacturing of diagnostic products, including blood culture tests products, could hinder the market growth.

Market Segmentation 2019-2029:
The blood culture test market is segmented on the method, application, product, technology, end user, and geography.

Method
• Manual Methods Market, 2019-2029
• Automated Methods Market, 2019-2029

Application
• Bacteremia Market, 2019-2029
• Fungemia Market, 2019-2029
• Mycobacterial Detection Market, 2019-2029

Product
• Consumables Market, 2019-2029
– Blood Culture Media Market, 2019-2029
– Assay Kits & Reagents Market, 2019-2029
– Blood Culture Accessories Market, 2019-2029
• Instruments Market, 2019-2029
– Automated Blood Culture Systems Market, 2019-2029
– Supporting Laboratory Equipment Market, 2019-2029
• Software and Services Market, 2019-2029

Technology
• Culture-Based Technology Market, 2019-2029
• Molecular Technologies Market, 2019-2029
• Proteomics Technology Market, 2019-2029

End User
• Hospital Laboratories Market, 2019-2029
• Reference Laboratories Market, 2019-2029
• Academic Research Laboratories Market, 2019-2029
• Others Laboratories Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood Culture Tests market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Becton, Dickinson and Company, Biomérieux SA, Thermo Fisher Scientific, Inc., Cepheid, Nanosphere, Inc., Danaher Corporation, Luminex Corporation, Roche Diagonistics, Bruker Corporation, T2 Biosystems, and Abbott Laboratories

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Blood Culture Tests Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Blood Culture Tests Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category